Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Zoetis Inc ZTS

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. It is engaged in commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).


NYSE:ZTS - Post by User

<< Previous
Bullboard Posts
Next >>
Post by whytestockson Apr 12, 2024 6:00pm
76 Views
Post# 35986808

Outperform Recommendation Issued On ZTS By William Blair

Outperform Recommendation Issued On ZTS By William Blair
NEWS: $ZTS Outperform Recommendation Issued On ZTS By William Blair2024-04-12 13:30:03 ET William Blair analyst issues OUTPERFORM recommendation for ZTS on April 12, 2024 12:11PM ET. The previous analyst recommendation was Outperform. ZTS was trading at $149.635 at issue of the analyst recommendation. The overall analyst consensus : BUY...ZTS - Outperform Recommendation Issued On ZTS By William Blair

<< Previous
Bullboard Posts
Next >>